0001209191-21-009760.txt : 20210211 0001209191-21-009760.hdr.sgml : 20210211 20210211170432 ACCESSION NUMBER: 0001209191-21-009760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210209 FILED AS OF DATE: 20210211 DATE AS OF CHANGE: 20210211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniel Jennifer CENTRAL INDEX KEY: 0001797725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 21620708 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-09 0 0001490978 Schrodinger, Inc. SDGR 0001797725 Daniel Jennifer C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 SVP & Chief HR Officer Common Stock 2021-02-09 4 M 0 2006 17.00 A 8694 D Common Stock 2021-02-09 4 S 0 2006 104.81 D 6688 D Common Stock 2021-02-10 4 M 0 2007 17.00 A 8695 D Common Stock 2021-02-10 4 S 0 2007 105.46 D 6688 D Common Stock 2021-02-11 4 M 0 2007 17.00 A 8695 D Common Stock 2021-02-11 4 S 0 2007 106.07 D 6688 D Stock Option (right to buy) 17.00 2021-02-09 4 M 0 2006 0.00 D 2030-02-05 Common Stock 2006 34113 D Stock Option (right to buy) 17.00 2021-02-10 4 M 0 2007 0.00 D 2030-02-05 Common Stock 2007 32106 D Stock Option (right to buy) 17.00 2021-02-11 4 M 0 2007 0.00 D 2030-02-05 Common Stock 2007 30099 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024. /s/ Donald Shum, as attorney-in-fact for Jennifer Daniel 2021-02-11